Trending...
- Seasoned Risk Stalwart Brian Hughes Joins Scienaptic As An Investor And Advisor
- ATM Processing Provider DNS Certifies Just.Cash Bitcoin Program
- Engine Prelubrication Systems Saves Money on both large and small engines
QView's AI-QVCAD, combined with GEHC's ABUS breast ultrasound system, potentially accelerates the acceptance of 3D breast ultrasound as supplemental screening for women with dense breast tissue.
LOS ALTOS, Calif. - DelhiScan -- QView, Inc., a medical technology leader providing artificial intelligence systems for breast cancer detection, and GEHC have signed a distribution agreement where QView Medical's AI-QVCAD software system will be added to GEHC's portfolio of breast imaging AI solutions for the detection and diagnosis of breast cancer.
Under the definitive agreement, GEHC will market and sell AI-QVCAD for its ABUS – Automated Breast Ultrasound System.
"QView working with GEHC is an excellent example of two organizations leveraging our mutual strengths and technological capabilities to provide a multimodality approach for breast screening. There is no single imaging screening solution," said Bob Wang, President, and CEO of QView, Inc
Mammography misses one-third of the cancers in screening women with dense breast tissue; breast density increases women's cancer risk 4-6 times, affecting more than 40 percent of women1. Earlier cancer detection is critical to increased survival rates, improved patient care, and reduced cost of care.
More on Delhi Scan
The ABUS 2.0 is the first FDA-approved Ultrasound supplemental breast screening technology specifically designed for detecting cancer in dense breast tissue. Adding AI-QVCAD software to the ABUS system is a powerful tool in detecting breast cancers earlier when they are more treatable, less invasive treatments, and improve patient quality of life.
Clinicians can now review AI-QVCAD results on the Invenia ABUS Viewer, streamlining clinical workflow and reducing the reading time by up to 33%2 while improving clinical outcomes with up to 93%3 sensitivity for lesion detection.
QView Medical supports all efforts to raise awareness of breast density as a significant risk factor - #DENSEBREASTINFO #AREYOUDENSE. QView supports passage of #FINDITEARLY Federal bill requiring health insurers to reimburse for screening and diagnostic breast ultrasound exams – no copay, no deductible.
About QView Medical, Inc.
QView Medical develops AI image-analysis systems for 3D Automated Breast Ultrasound Systems ABUS). The QView team has been the leader in AI technologies and breast cancer detection for over twenty-five years, including developing R2 mammography CAD, R2 lung CT CAD, U-Systems ABUS, and QView AI QVCAD. Visit our website www.qviewmedical.com for more information.
More on Delhi Scan
--
Under the definitive agreement, GEHC will market and sell AI-QVCAD for its ABUS – Automated Breast Ultrasound System.
"QView working with GEHC is an excellent example of two organizations leveraging our mutual strengths and technological capabilities to provide a multimodality approach for breast screening. There is no single imaging screening solution," said Bob Wang, President, and CEO of QView, Inc
Mammography misses one-third of the cancers in screening women with dense breast tissue; breast density increases women's cancer risk 4-6 times, affecting more than 40 percent of women1. Earlier cancer detection is critical to increased survival rates, improved patient care, and reduced cost of care.
More on Delhi Scan
- Abusive Russian to face Pro Wrestling Legend!
- Jim Wilson, Top Notch Realtor in waterfront and beach properties in Redington, Redington Shores, and North Redington Beach, FLorida
- Multi #1 International Best-Selling Author Jennifer S. Wilkov Announces the 2023 April Speak Up Women Conference and Call For Speakers
- Cascade Asset Management Releases its 9th Annual IT Asset Disposition Benchmarking Report
- Electives, Inc. doubles its live learning library to include more than 450 classes
The ABUS 2.0 is the first FDA-approved Ultrasound supplemental breast screening technology specifically designed for detecting cancer in dense breast tissue. Adding AI-QVCAD software to the ABUS system is a powerful tool in detecting breast cancers earlier when they are more treatable, less invasive treatments, and improve patient quality of life.
Clinicians can now review AI-QVCAD results on the Invenia ABUS Viewer, streamlining clinical workflow and reducing the reading time by up to 33%2 while improving clinical outcomes with up to 93%3 sensitivity for lesion detection.
QView Medical supports all efforts to raise awareness of breast density as a significant risk factor - #DENSEBREASTINFO #AREYOUDENSE. QView supports passage of #FINDITEARLY Federal bill requiring health insurers to reimburse for screening and diagnostic breast ultrasound exams – no copay, no deductible.
About QView Medical, Inc.
QView Medical develops AI image-analysis systems for 3D Automated Breast Ultrasound Systems ABUS). The QView team has been the leader in AI technologies and breast cancer detection for over twenty-five years, including developing R2 mammography CAD, R2 lung CT CAD, U-Systems ABUS, and QView AI QVCAD. Visit our website www.qviewmedical.com for more information.
More on Delhi Scan
- Bottled Ambrosia Launches to Provide Access to the Best European Organic Baby Formulas for US and Canadian Families
- Yida Gao, Shima Capital Recognized for Prolific Deal Activity
- Southern California Real Estate Agent Promotes Homes To MORE Buyers For MORE Money
- Can Massage Therapy Be an Effective Treatment for Long Haul COVID?
- STS Capital Partners Announces Sean Friday as New Chief Executive Officer
--
- Boyd, et al, NEJM Jan 2007
- Interpretation Time Using a Concurrent-Read Computer-Aided Detection System for Automated Breast Ultrasound in Breast Cancer Screening of Women with Dense Breast Tissue (Yulei Jiang). Read More: https://www.ajronline.org/doi/10.2214/AJR.18.19516
- Performance and Reading Time of Automated Breast US with or without Computer-aided Detection. Read More: https://pubs.rsna.org/doi/10.1148/radiol.2019181816
Source: Qview Medical, Inc.
0 Comments
Latest on Delhi Scan
- "Breaking Three Hours-Trailblazing African American Women Marathoners" Available on Prime Video
- Jeron Pro-Alert™ Area of Rescue System is First to Reach UL2525 Listing
- Evins Communications Accelerates Growth with Acquisition of Teuwen Communications
- SimpleCRM Included in Top Analyst Report on 15 Industry-Specific CRMs
- Patton Taps Rich Coursey to Lead its New Contract Engineering, Design, and Manufacturing Division
- DLR Launches Ground-breaking Robot Control Software
- Noodle Girl, Chef Hang Truong, Launches Crispy Corn Snack Nationwide for Lunar New Year
- Astro Dunia Launches Annual Letter 2023: A Financial Astrology Solution for Investors
- Shelter Structures America Introduces Allura Event Furniture to Brand Portfolio
- Sammy Vélez's New Single "Cajón, Guitarra Y Son" To Be Released Worldwide On January 27th
- SnappyFlow adds Security Incident and Event Management Feature to its Observability Suite
- Quala Selects PhaseZero to Modernize its Digital Customer Experience
- Free Guided Grief Journal Program Launches on MLK Day of Service
- LCS Capital LLC v. Steven Zale, Case No. 22CHCV00004 Dismissal/Settlement Filed
- THE PROJECTION BOOTH Podcast Celebrates 12 Years With Continued Quality and Amazing Guests!
- Best Real Estate Brokerage to Work for
- Ty'Shawn Brooks – United Real Estate
- Dog Gone Feel Good Movie Premier
- West Bend Area Real Estate Agent Promotes Homes To MORE Buyers For MORE Money